ArticleBreast cancer research and treatment2021

HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.

Takaaki Oba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.